<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860565</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.187</article-id><article-id pub-id-type="other">O0058</article-id><article-id pub-id-type="pii">S0924933824001871</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>Oral Communication</subject></subj-group></article-categories><title-group><article-title>Evidence-Informed Approach to De-Prescribing of Atypical Antipsychotics (AAP) in the Management of Behavioral Expressions (BE) in Advanced Neurocognitive Disorders (NCD): Results of a Retrospective Study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Luthra</surname><given-names>A. S.</given-names></name><xref rid="aff0209" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0048" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>LinBin Gao</surname><given-names>R.</given-names></name><xref rid="aff0210" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Carducci</surname><given-names>P.</given-names></name><xref rid="aff0211" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sue</surname><given-names>J.</given-names></name><xref rid="aff0212" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Remers</surname><given-names>S.</given-names></name><xref rid="aff0213" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="aff0209"><sup>1</sup>Department of Psychiatry and Behavioural Neurosciences, <institution>McMaster University</institution></aff><aff id="aff0210"><sup>2</sup>Department of Pharmacy, St. Peter&#x02019;s Hospital, <city>Hamilton</city></aff><aff id="aff0211"><sup>3</sup>School of Pharmacy, University of Waterloo, <city>Waterloo</city></aff><aff id="aff0212"><sup>4</sup>Clinical Neuropsychologist, St. Peter&#x02019;s Hospital, <city>Hamilton</city></aff><aff id="aff0213"><sup>5</sup>Homewood Health Inc, <city>Guelph</city>, <country>
Canada</country></aff><author-notes><corresp id="cor0048"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="162">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S68</fpage><lpage>S69</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824001871a.pdf"/><abstract><sec id="sec0285"><title>Introduction</title><p>Diagnosis of behaviors in advanced neurocognitive disorders (aNCD) is one of exclusion, and the framework has been laid out in DSM-V. However, clinical assessments in aNCD become increasingly unreliable, and commonly used psychometric tools for clinical assessments lack reliability and validity, thereby making outcomes unreliable. Consequently, the syndromic and symptom management approaches for behaviors in aNCD behaviors have yielded poor results. To address this, the focus has shifted towards understanding the &#x02018;meaning&#x02019; of behaviors in aNCD, recognizing them as a &#x02018;mode of communication&#x02019;. To date, there are no existing frameworks to ascribe &#x02018;meaning&#x02019; to behaviors in aNCD.</p></sec><sec id="sec0286"><title>Objectives</title><p>LuBAIR&#x02122; paradigm is the first step in offering such a framework for understanding the &#x02018;purpose&#x02019; and &#x02018;meaning&#x02019; of behaviors in NCD.&#x000a0;The &#x02018;meaning&#x02019; ascribed to each behavioral category was used to guide the use of atypical antipsychotics in their management.&#x000a0;De-prescribing was attempted on patients who qualified to enter this retrospective study. De-prescribing was defined as successful if individuals were completely withdrawn from AAP and remained off them for 60 days without the re-emergence of behaviors.</p></sec><sec id="sec0287"><title>Methods</title><p>The data collected on the second occasion, in the successful and failed de-prescribed groups, were compared in this retrospective study. MANOVA, Chi-Square paired <italic toggle="yes">t</italic>-test statistical analyses were used to detect the differences in the behavioral categories between the two cohorts. Cohen d was used to measure effect size.</p></sec><sec id="sec0288"><title>Results</title><p>Patients who did not have Mis-Identification and Goal-Directed Expressions were more likely to successfully de-prescribe: X2 (1,&#x000a0;<italic toggle="yes">N</italic>&#x000a0;= 40) = 29.119&#x000a0;<italic toggle="yes">p</italic>&#x000a0;&#x0003c; 0.0001 and X2 (1,&#x000a0;<italic toggle="yes">N</italic>&#x000a0;= 40) = 32.374,&#x000a0;<italic toggle="yes">p</italic>&#x000a0;&#x0003c; 0.0001, respectively. Alternatively, the same behavioral categories were more likely present in patients who failed de-prescribing: MANOVA and paired&#x000a0;<italic toggle="yes">t</italic>-test (<italic toggle="yes">p</italic>&#x000a0;&#x0003c; 0.0001). Atypical antipsychotics, in their role as an antipsychotic and mood stabilizer, may be used to manage Mis-Identification and Goal-Directed Expressions, respectively.</p></sec><sec id="sec0289"><title>Conclusions</title><p>LuBAIR paradigm has the potential to guide the development of specific behavioral care plans and the use of AAP in managing individual behavioral categories.&#x000a0;AAP use can be justified for managing Misidentification and Goal-Directed Expressions.&#x000a0;Vocal expressions may warrant the use of AAP, pending further study.&#x000a0;The LuBAIR paradigm offers guidance for de-prescribing AAP for all other behavioral categories in the LuBAIR Inventory.&#x000a0;This study is also a preliminary step in validating the psychological theories used to support the individual categories.&#x000a0;This workshop will educate the participants on the LuBAIR paradigm and its application in developing person-centered interventions for behaviors in a NCD.</p></sec><sec id="sec0290"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>